Pulmonary hypertension
Pulmonary hypertension is an extremely serious disease. 75% of patients are concentrated in the age group of 20 to 40 years old, and 15% of patients are under 20 years old. Symptoms of pulmonary hypertension include shortness of breath, easy fatigue, syncope, chest pain, and leg and ankle edema. In addition, hyperactivity of P2 can be heard by auscultation of the heart. If not treated in time, the patient's pulmonary hypertension will gradually worsen and even shorten his life. Most symptoms related to pulmonary hypertension originate from right heart failure.
-
Site of disease:
Lungs and heart -
Infectious :
Not contagious -
Frequent population:
There is no special disease group, 75% of patients are concentrated... -
Related symptoms:
exertional dyspnea chest pain fatigue hoarseness enlarged liver -
Concurrent disease:
Related Drugs
Sodium ferulate
Indication: It is mainly used for auxiliary treatment of vascular diseases such as atherosclerosis, coronary heart disease, cerebrovascular disease, glomerular disease, pulmonary hypertension, diabetic vascular disease, vasculitis, etc. It can also be used for the treatment of migraine and vascular headache.
Manufacturer:
Chengdu Hengda Pharmaceutical Co., Ltd.
Sodium ferulate
Indication: It is mainly used for auxiliary treatment of vascular diseases such as atherosclerosis, coronary heart disease, cerebrovascular disease, glomerular disease, pulmonary hypertension, diabetic vascular disease, vasculitis, etc. It can also be used for the treatment of migraine and vascular headache.
Manufacturer:
Yaopharma Co., Ltd.
Sodium ferulate
Indication: It is mainly used for auxiliary treatment of vascular diseases such as atherosclerosis, coronary heart disease, cerebrovascular disease, glomerular disease, pulmonary hypertension, diabetic vascular disease, vasculitis, etc. It can also be used for the treatment of migraine and vascular headache.
Manufacturer:
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd.
Ventavir Iloprost Solution for Inhalation
Indication: Treatment of moderate primary pulmonary hypertension.
Iloprost solution for inhalation
Indication: Treatment of moderate primary pulmonary hypertension.
Iloprost solution for inhalation
Indication: Treatment of moderate primary pulmonary hypertension.
Iloprost solution for inhalation
Indication: Treatment of moderate primary pulmonary hypertension.
Isosorbide dinitrate sustained-release capsules
Indication: Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure; treatment of pulmonary hypertension.
Manufacturer:
Shanghai Ethypharm Pharmaceuticals Co., Ltd.
Isosorbide dinitrate sustained-release capsules
Indication: Prevention and treatment of angina pectoris caused by coronary artery disease.
Manufacturer:
Shanghai Ethypharm Pharmaceuticals Co., Ltd.
Ambrisentan Tablets
Indication: It is indicated for the treatment of patients with pulmonary hypertension with WHO grade II or III symptoms (WHO group 1) to improve exercise capacity and delay clinical deterioration.